25 May 2013
Keywords: sanofi, novozymes, sign, antibiotic, deal, french, drug
Article | 12 January 2009
French drug major Sanofi-Aventis has signed a global licensing and collaboration agreement with UK-based Novozymes for the development and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2009
24 May 2013
© 2013 thepharmaletter.com